Scope: To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans. Methods and results: Gut microbiota composition and gene markers of browning are analyzed in subcutaneous (SAT) and visceral (VAT) adipose tissue from morbidly obese subjects (n = 34). Plasma acetate is measured through 1 H NMR and insulin sensitivity using euglycemic hyperinsulinemic clamp. Subjects with insulin resistance show an increase in the relative abundance (RA) of the phyla Bacteroidetes and Proteobacteria while RA of Firmicutes is decreased. In all subjects, Firmicutes RA is negatively correlated with HbA 1c and fasting triglycerides, whereas Proteobacteria RA was negatively correlated with insulin sensitivity. Firmicutes RA is positively associated with markers of brown adipocytes (PRDM16, UCP1, and DIO2) in SAT, but not in VAT. Multivariate regression analysis indicates that Firmicutes RA contributes significantly to SAT PRDM16, UCP1, and DIO2 mRNA variance after controlling for age, BMI, HbA 1c , or insulin sensitivity. Interestingly, Firmicutes RA, specifically those bacteria belonging to the Ruminococcaceae family, is positively associated with plasma acetate levels, which are also linked to SAT PRDM16 mRNA and insulin sensitivity. Conclusion: Gut microbiota composition is linked to adipose tissue browning and insulin action in morbidly obese subjects, possibly through circulating acetate.
Introduction
Human gut microbiota genes contribute more in human physiology than the whole human genome, reflecting a close symbiotic association between eukaryotic cells and microbes (100 trillion) in human gut. [1, 2] Abundance and gut microbiota composition is significantly influenced by the metabolic state of the host, diet, and medication. [3, 4] Mice experiments showed an important role of gut microbiota in the modulation of both energy balance and energy stores through the generation of specific molecules (such as short-chain fatty acids). [3, 4] The dominant phyla in the gut are Firmicutes (60-65%), Bacteroidetes (20-25%), Proteobacteria (5-10%), and Actinobacteria (3%), which together constitute over 97% of the gut microbe population. [4] In rodents, obesity is associated with increased Firmicutes and decreased Bacteroidetes relative abundance, in parallel to decreased gut microbiota composition diversity, www.advancedsciencenews.com www.mnf-journal.com possibly due to both weight gain and high-fat diet. [4, 5] There is much greater variability in human studies. Some studies report a similar increase in the ratio of Firmicutes/Bacteroides, as well as a decrease in the gut biodiversity in obese humans, but there are also numerous studies reporting contradictory findings in obese versus lean humans. [6, 7] Two recent studies demonstrated that cold exposure [8] or intermittent fasting [9] led to dramatic changes of the microbiota composition, increasing Firmicutes versus Bacteroidetes relative abundance. Interestingly, this shift in microbiota composition is associated to a phenotype of increased capacity of energy extraction, characterized by increased intestinal absorptive surface area and browning of the white adipose tissue. [8, 9] In mice, browning of white adipose tissue prevents obesity-associated metabolic disturbances and insulin resistance. [10, 11] In humans, expression of markers of browning in subcutaneous adipose tissue has been associated to insulin sensitivity, a relatively healthy obese phenotype, and adipose tissue function. [12] [13] [14] To the best of our knowledge, the interaction between microbiota and adipose tissue physiology has not been previously investigated in humans. Given the potential importance of adipose tissue inter-relationships with microbiota and insulin action in human obesity, here we aimed to examine the associations among adipose tissue markers of browning (PRDM16, UCP1, and DIO2), insulin sensitivity (SLC2A4 and IRS1), and gut metagenomic microbiota composition in morbidly obese participants. We also studied adipose tissue markers of adipogenesis (ADIPOQ, PPARG) and chronic proinflammatory activity inflammation (TNF and IL6). Metabolomic analyses ( 1 H NMR spectra) were also performed.
Experimental Section

Recruitment of Patients and Processing of Samples
The human cohort comprised 34 morbidly obese women (n = 28) and men (n =6), recruited at the Endocrinology Service of the Hospital Universitari de Girona "Dr Josep Trueta" (Girona, Spain) included in the FLORINASH project. Thirteen patients had newly diagnosed type 2 diabetes. Eighteen out of the 34 subjects also received antihypertensive therapy and 9 hypolipemiant drugs. Pre-established inclusion criteria: all subjects were of Caucasian origin and reported a stable body weight at least three months preceding the study, were free of any infections and antibiotic treatment for one month before inclusion, and had no systemic disease. Pre-established exclusion criteria: subjects with liver disease, specifically HCV infection and tumor disease, and subjects with thyroid dysfunction were excluded by biochemical workup.
Subcutaneous (SAT) and visceral adipose tissue (VAT) samples were obtained from all subjects during elective gastric bypass surgery, immediately transported to the laboratory, and processed under strictly aseptic conditions. Adipose tissue samples were washed in PBS, cut off with forceps and scalpel, and immediately flash-frozen in liquid nitrogen before being stored at −80°C.
Euglycemic Hyperinsulinemic Clamp
Insulin action was determined by the euglycemic hyperinsulinemic clamp 1 week before surgery. [15] After an overnight fast, two catheters were inserted into an antecubital vein, one for each arm, used to administer constant infusions of glucose and insulin, and to obtain arterialized venous blood samples. A 2-h euglycemic hyperinsulinemic clamp was initiated by a two-step primed infusion of insulin (80 mU/m 2 /min for 5 min, 60 mU/m 2 /min for 5 min) immediately followed by a continuous infusion of insulin at a rate of 40 mU/m 2 /min (regular insulin; Actrapid, Novo Nordisk, NJ). Glucose infusion began at minute 4 at an initial perfusion rate of 2 mg/kg/min, then was adjusted to maintain plasma glucose concentration at 4.9-5.5 mmol L -1 . Blood samples were collected every 5 min for determination of plasma glucose and insulin. Insulin sensitivity was assessed as the mean glucose infusion rate during the last 40 min. In the stationary equilibrium, the amount of glucose administered (M) equals the glucose taken by the body tissues and is a measure of overall insulin sensitivity. Subjects in the upper tertile of glucose infusion rate during the clamp were considered as insulin sensitive.
All subjects gave written informed consent, validated and approved by the Ethical Committee of the Hospital of Girona "Dr Josep Trueta", after the purpose of the study was explained to them.
Gut Microbiota Composition
Total DNA was extracted as previously described. [16] [17] [18] [19] [20] [21] [22] Briefly, the whole 16S bacterial DNA V2 region, as well as part of V1 and V3, were targeted by the 28F-519R primers [16] [17] [18] and analyzed by pyrosequencing by the 454 FLX Roche technologies at Research&Testing Laboratory (http:// www.researchandtesting.com/, Texas, USA). An average of 5000 sequences was generated per sample. A full description of bioinformatic filters is available at http://www.rtlgenomics.com/docs/ Data_Analysis_Methodology.pdf.
Metabolomic Analyses
For metabolomic analyses, plasma was collected after an overnight fast. All 1 H NMR spectra were acquired using Bruker DRX600 spectrometers (Rheinstetten, Germany) running under TopSpin, with either a 5 mm TXI probe operating at 600.13 MHz or a 5 mm BBI probe operating at 419 600.44 MHz. All runs were carried out using Bruker BACS60 sample handling automation; prior to each run the 90°pulse length was determined and set for the run. The field frequency was locked on D 2 O as solvent. In all experiments, water suppression was carried out by noise irradiation during the 2 s recycle delay (RD). For all experiments, 128 scans were recorded into 32 K data points with a spectral width of 20 ppm, and an exponential function was applied to the FID prior to the Fourier transformation, which resulted in a line broadening of 0.3 Hz. All plasma NMR spectra were automatically phased, baseline-corrected, and referenced to the center of the α-glucose anomeric doublet (δ 5.23) for plasma, using an www.advancedsciencenews.com www.mnf-journal.com in-house MatLab (The MathWorks, Natick, Massachusetts) scripts. Baseline and peak alignment quality control was done by individual verification for each spectrum and occasionally a spectrum was manually adjusted.
RNA Expression
RNA purification, gene expression procedures, and analyses were carried out, as previously described. [14, 15] Briefly, RNA purification was performed using the RNeasy Lipid Tissue Mini Kit (Qiagen, Izasa SA, Barcelona, Spain) and the integrity was checked by the Agilent Bioanalyzer (Agilent Technologies, Palo Alto, CA). Gene expression was assessed by real-time PCR using a LightCycler R 480 Real-Time PCR System (Roche Diagnostics SL, Barcelona, Spain), using TaqMan R technology suitable for relative genetic expression quantification. The commercially available and pre-validated TaqMan R primer/probe sets used were detailed elsewhere. [14, 15] 
Analytical Methods
Serum glucose, insulin, HOMA-IR, HDL-cholesterol, fasting triglycerides, and C-reactive protein concentration measurement were performed as previously described. [14, 15] 
Statistical Analyses
Statistical analyses were performed using SPSS 12.0 software. Unless otherwise stated, descriptive results of continuous variables are expressed as mean and SD for Gaussian variables or median and interquartile range. Parameters that did not fulfil normal distribution criteria were Log transformed to improve symmetry for subsequent analyses. The relation between variables was analyzed by simple correlation (Pearson's test and Spearman's test) and multiple regression analyses in a stepwise manner. Levels of statistical significance were set at p < 0.05.
Results
Anthropometrical and metabolic parameters are described in Table 1 . In obese subjects with insulin resistance, gut Firmicutes relative abundance (RA) was decreased, whereas Bacteroidetes and Proteobacteria RA were increased compared with insulin sensitive subjects (Table 1 ). These observations were in parallel to reduced SAT SLC2A4 (also named GLUT4), a tendency towards reduced VAT IRS-1 (p = 0.06), and reduced SAT PRDM16 mRNA among insulin resistant subjects (Table 1) .
Firmicutes RA was negatively correlated with HbA 1c (r = −0.37, p = 0.03) and fasting triglycerides (r = −0.35, p = 0.04), whereas Proteobacteria RA was positively correlated with HOMA-IR (r = 0.35, p = 0.04) and negatively with insulin sensitivity (r = −0.38, p = 0.03).
Interestingly, Firmicutes RA was positively correlated with markers of brown adipocytes (PRDM16 (r = 0.42, p = 0.01), PRDM16 mRNA levels were also negatively correlated with Proteobacteria RA (r = −0.37, p = 0.03), but this association did not remain significant after controlling for age, BMI, or insulin sensitivity.
Multivariate regression analysis indicated that Firmicutes RA contributed significantly to SAT PRDM16 and UCP1 mRNA variance after controlling for age. In other models, we substituted age for one of the following variables: sex, BMI, insulin sensitivity (M value), HbA 1c , type 2 diabetes, antihypertensive therapy or hypolipemiant drugs ( Table 2) . Firmicutes RA also contributed significantly to SAT DIO2 mRNA variance after controlling for age, sex, insulin sensitivity (M value), and HbA 1c ( Table 2) .
To explore the possible mechanism underlying the relationship between microbiota and adipose tissue browning, and considering the effects of circulating acetate on adipocyte browning and fat oxidation, [23] [24] [25] [26] [27] its major abundance compared to other important gut microbial-derived short-chain fatty acids (propionate and butyrate), [28] and its capacity to transfer from colon into bloodstream, [23] circulating acetate levels in plasma were examined. Circulating acetate levels were significantly increased in insulin sensitive obese participants (Figure 2a , Table 1 ) in positive correlation with gut Firmicutes RA, SAT PRDM16 mRNA, and insulin sensitivity (Figure 2b-d) , and negatively correlated with HOMA-IR and fasting triglycerides (Figure 2e, f) . 3-Hydroxybutyrate, but not propionate, was also detected by 1 H NMR spectroscopy. However, no significant differences of circulating 3-hydroxybutyrate levels according to insulin sensitivity were found (Table 1) . Circulating 3-hydroxybutyrate levels were not correlated with gut Firmicutes RA (r = 0.06, p = 0.7), SAT PRDM16 mRNA (r = −0.18, p = 0.3), insulin sensitivity (r = −0.05, p = 0.8), HOMA-IR (r = −0.07, p = 0.7), or fasting triglycerides (r = −0.14, p = 0.4).
Finally, within families from the Firmicutes phylum, only those bacteria from Ruminococcaceae family, which was the most abundant (Figure 2g ), were positively correlated with insulin sensitivity (r = 0.48, p = 0.01), plasma acetate (r = 0.52, p = 0.005), and PRDM16 mRNA levels (r = 0.43, p = 0.02), and negatively correlated with fasting triglycerides (r = −0.37, p = 0.04) (Figure 3) . Multivariate regression analysis indicated that plasma acetate contributed significantly to SAT PRDM16 mRNA variance after controlling for age, sex, BMI, insulin sensitivity (M value) and type 2 diabetes, antihypertensive therapy or hypolipemiant drugs, but not after controlling for family Ruminococcaceae RA ( Table 3 ).
Discussion
In the current study, we investigated gut microbial composition and markers of adipose tissue browning in morbidly obese subjects. To the best of our knowledge, no previous studies have explored these associations in humans. The main findings indicate that Firmicutes RA, specifically those bacteria from Ruminococcaceae family, was positively associated with insulin action in parallel to increased markers of browning in SAT. A previous study demonstrated that cold exposure, with its associated increased energy harvest, led to dramatic changes of the www.advancedsciencenews.com www.mnf-journal.com microbiota composition in mice, increasing Firmicutes versus Bacteroidetes RA in association with browning of white adipose tissue. Interestingly, this shift in microbiota composition is associated to a phenotype of increased capacity of energy extraction, characterized by increased intestinal absorptive surface area and browning of the white adipose tissue. [8] These changes resulted in improved insulin sensitivity, increased energy expenditure, and fat loss. [8] In line with this, a recent study demonstrated that brown bears during their active phase (summer) become obese, but remain metabolically healthy, in parallel to increased Firmicutes relative abundance. [29] Interestingly, transplantation of the bear microbiota from active phase (increased ratio of Firmicutes/Bacteroidetes) to germ-free mice promoted adiposity, but improved glucose metabolism. [29] Furthermore, a recent study demonstrated that increased Firmicutes relative abundance and Firmicutes-induced acetate biosynthesis during intermittent fasting was required to induce inguinal white adipose tissue browning and, in consequence, improved obesity-associated metabolic disturbances. [9] These studies might explain the dual role of Firmicutes-enriched microbiota in energy harvesting (inducing obesity) and in thermogenesis (preserving insulin sensitivity).
In humans, this shift in microbial composition has been previously associated with significantly increased energy harvest. [30] A significant reduction in bacterial species from Firmicutes phylum and increased RA of bacterial species from Proteobacteria and Bacteroidetes phyla are known to be associated with insulin resistance and type 2 diabetes. [31] [32] [33] [34] [35] [36] [37] Markers of browning (PRDM16 and UCP1) in SAT have been also linked to insulin sensitivity. [11] [12] [13] The mechanisms to explain the relationship between Ruminococcaceae RA and markers of browning in SAT remain to be elucidated. Gut microbial-derived SCFAs have been demonstrated to improve insulin sensitivity through the enhancing of fat oxidation and energy expenditure. [22, 27, 38] Acetate seems to exert a crucial role in brown adipocyte differentiation through the induction of mitochondrial biogenesis, [23] leading to increased oxygen consumption rate in white and brown adipocytes and skeletal muscle from Otsuka Long-Evans Tokushima Fatty rats [24] ; and increased browning of SAT in parallel to increased insulin sensitivity in mice. [25] Acetate administration also resulted in increased expression of browning genes (PRDM16, UCP1, and DIO2) in 3T3-L1 cells and in white adipose tissue from obese diabetic KK-A y mice in parallel to increased whole-body oxygen consumption, [26] leading to enhanced fat oxidation. [27, 39, 40] In animal models, reduced Firmicutes RA and serum acetate and increased Bacteroidetes RA were concomitant to lower glucose infusion rate during a hyperinsulinemic euglycemic clamp in mice. [41] The recovery of serum acetate levels (using antibiotics or acetate administration) led to improved insulin sensitivity and attenuated adipose tissue macrophage infiltration in adipose tissue. [41] In humans, distal colonic acetate infusion resulted in increased whole-body fat oxidation. [23] Multivariate regression analysis indicated that the association between plasma acetate and SAT PRDM16 mRNA remained significant after controlling for age, sex, BMI, insulin sensitivity (M value) and diabetes, hypertension, or dyslipemia therapy, but not after controlling for family Ruminococcaceae RA, suggesting this bacterial family as the most important source of plasma acetate. In agreement with this suggestion, one recent study found acetate biosynthesis to be correlated with Firmicutes RA, [42] being those bacteria from Ruminococcaceae family (which was the most abundant) www.advancedsciencenews.com www.mnf-journal.com considered as important acetate-producing bacteria in rumen studies. [43] Acetate, propionate, and butyrate colonic infusions increased fasting fat oxidation and resting energy expenditure in overweight/obese men, [44] suggesting positive effects of these SCFAs on insulin sensitivity. Even though, in current study only plasma acetate was associated with insulin sensitivity.
In the current study, plasma acetate was measured after an overnight fast. Of note, fasting state might reflect better endogenous bacterial acetate production, whereas the contribution of exogenous acetate sources should be considered in postprandial state.
The effects of nutrition and physical activity on gut microbiota composition and functionality have been extensively demonstrated. [4, 45] One limitation of current study is that data on nutritional intake, physical activity, or food supplements were not considered as confounding variables. This is the first study, to our knowledge, to describe associations among glucose infusion rate during euglycemic hyperinsulinemic clamp, gut microbiota composition, and markers of browning in SAT in morbidly obese subjects.
The absence of association between Firmicutes RA and markers of browning in VAT might be explained by the lower capacity of this fat depot to develop browning. [9, 46] The current study extends to humans' previous observations in mice regarding gut microbiota composition and adipose tissue browning, [8] and suggests a possible mechanism to explain them through increased plasma acetate levels. Further intervention studies exploring the possible role of acetate in adipose tissue browning and insulin sensitivity are required to confirm current findings.
Abbreviations
HOMA-IR, homeostatic model assessment of insulin resistance; M, insulin action value measured by the euglycemic hyperinsulinemic clamp; RA, relative abundance; RU, relative units of gene expression; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue
